Health / Medical Topics

    Morphine Sulfate Sustained-Release Tablet

    A sustained-release tablet formulation containing the sulfate salt of the opiate alkaloid morphine with analgesic activity. Morphine binds to and activates the mu-opioid receptors in the central nervous system (CNS), thereby mimicking the effects of the endogenous opioids. Binding of morphine to opioid receptors stimulates exchange of GTP for GDP, inhibits adenylate cyclase, and decreases intracellular cAMP. This inhibits the release of various nociceptive neurotransmitters, such as substance P, gamma-aminobutyric acid (GABA), dopamine, acetylcholine, noradrenaline, vasopressin, and somatostatin. In addition, morphine closes N-type voltage-gated calcium channels and opens calcium-dependent inwardly rectifying potassium channels, which results in hyperpolarization of neuronal membranes and a reduction in neuronal excitability, and subsequently, analgesia and sedation. (NCI Thesaurus)




    YOU MAY ALSO LIKE

    A drug used to treat moderate to severe pain. It binds to opioid receptors in the central nervous system and some other…
    The determination of the amount of morphine present in a sample.
    An opiate alkaloid isolated from the plant Papaver somniferum and produced synthetically. Morphine binds to and activates specific opiate receptors (delta, mu…
    A heterocyclic biguanidine with activity against influenza and other viral infections. Although its mechanism of action is not fully known the effects…
    A country in northern Africa, bordering the North Atlantic Ocean and the Mediterranean Sea, south of Spain and between Algeria and Western…
    An involuntary, primal response in the neonate to loud noise or the feeling of falling. The response is characterized by the infant's…

    © 1991-2023 The Titi Tudorancea Bulletin | Titi Tudorancea® is a Registered Trademark | Terms of use and privacy policy
    Contact